Research Article

Development and Validation of a Stability-Indicating HPTLC Method for Analysis of Rasagiline Mesylate in the Bulk Drug and Tablet Dosage Form

Table 3

Robustness testing ( ).

Parameters% RSD

% change in mobile phase
Chamber saturation time
Development distance
Time from application to development
Time from development to scanning